Latest News

We’re pleased to share a new corporate video of our CEO Mike Davies. In the video, he discusses Carocell Bio, its technology, and how it could

Cheadle, UK – 10 January 2022 – Today, Carocell Bio, the anti-inflammation therapeutics company, announced that its lead anti-inflammatory peptide JEL0305 shows efficacy in human

Greater Manchester, UK – 14 Dec 2022 – Today, Carocell Bio, the anti-inflammation therapeutics company, announced that it has received USD $500,000 (£404,000) in further

GREATER MANCHESTER, UK – 13 June 2022 – Carocell Bio, the anti-inflammation company revolutionising the treatment of inflammatory diseases with its peptide-based approach to mitogen-activated

GREATER MANCHESTER, UK – 6 June 2022 – Today, Carocell Bio, the anti-inflammation company revolutionising the treatment of inflammatory diseases with its peptide-based approach to

Testing anti-inflammation approach to treat burns and scarring is key step in therapeutic development and potential progression to clinical testing GREATER MANCHESTER, UK – 17

Interview with Dr Mike Davies, Founder and CEO, Carocell Bio In this Q&A Dr Davies reflects on his career to-date, including his background in surgery

GREATER MANCHESTER, UK – Carocell Bio, the UK- and US-based company focused on the development of anti-inflammatory therapeutics, announced that today, Thursday, 24 February 2022,

GREATER MANCHESTER, UK – Carocell Bio, the UK-based company focused on the development of anti-inflammatory therapeutics, is pleased to announce that its CEO, Dr Mike

GREATER MANCHESTER, UK – Today Carocell Bio, the anti-inflammation therapeutics company, announced that it has been awarded additional funding from Innovate UK. The grant aims

GREATER MANCHESTER, UK – Today, Carocell Bio, the UK-based anti-inflammation therapeutics company, is pleased to announce a further £150,000 in funding from Deepbridge Capital. The

GREATER MANCHESTER, UK – Today, Carocell Bio, the UK-based anti-inflammation therapeutics company, has been awarded an Innovate UK Smart grant of over £270,000 for the

GREATER MANCHESTER, UK – Today, Carocell Bio, the anti-inflammation therapeutics company, announced that it has received £250,023.32 from Deepbridge Capital, an investment firm focused on

BioSeed 2020, London – January 20, 2020 GREATER MANCHESTER, UK – Carocell Bio will be presenting at BioSeed 2020, we look forward to seeing you

38th J.P. Morgan Healthcare Conference, San FranciscoJanuary 13-16, 2020 GREATER MANCHESTER, UK – Carocell Bio will be attending the 38th J.P Morgan Healthcare Conference on

BioEurope 2019, Hamburg – Nov 11-13, 2019 GREATER MANCHESTER, UK – Dr Mike Davies will be present and available for meetings. We very much look

Inv€$tival Showcase 2019, London – Nov 19, 2019 GREATER MANCHESTER, UK – Carocell Bio will be attending the conference and available for meet anyone interested

GREATER MANCHESTER, UK – Today, Carocell Bio is pleased to announce that it recently changed its company name, from Bridge Biotec. The company looks forward